Добавить новость
smi24.net
News in English
Май
2023

Новости за 04.05.2023

Abortion giant brags about remaining 'relentless' in killing babies

WND 

(STREAM) – Planned Parenthood has trumpeted its huge profits and boasted of aborting 1,025 babies each day in its 2021-2022 Annual Report. American Life League and its Planned Parenthood watchdog STOPP International state that the abortion vendor should be ashamed of its self-proclaimed “relentless” pursuit of unrestricted abortion. “The 40-page report features over 170 repetitions…

Читать дальше...



: Kenvue stock opens 16% above IPO, valuing the company at $47.7 billion

MarketWatch.com 

Kenvue Inc. shares KVUE were cheered in their Wall Street debut Thursday, as the Johnson & Johnson JNJ spinoff, with consumer brands including Tylenol, Band-Aid and Listerine, saw it’s stock open 16.0% above its initial public offering price. Kenvue raised $3.8 billion as it said late Wednesday that it sold 172.8 million shares in the IPO, up from previous expectations of 151.2 million shares, at $22 a share, which was at the higher end of the expected pricing range of between $20 and $23 a share. Читать дальше...

'Thugs don't dance'

NPR (npr.org) 

In 2016, a rift between hitmakers showed the limits of rap's tolerance for rule-breakers. As Mark Anthony Neal explains, "authentic" Black masculinity has always been a moving target in hip-hop.

Taibbi And Musk Are Not The Story

OpEdNews.com 

Taibbi has been a journalist, and let the chips fall wherever, which also means, never become part of the story you're reporting. That's high praise (well-deserved I think), and a near-impossibility in this case, even without an embarrassed media establishment hellbent on making him the villain of the story, in hopes of a spectacle that could displace the real story. Which also says something about culture.

J&J's consumer-health spinoff Kenvue jumps 20% in public market debut - CNBC

Top Stories (us) - Google News (com) 

  1. J&J's consumer-health spinoff Kenvue jumps 20% in public market debut  CNBC
  2. J&J’s Kenvue Prices IPO at $22 Per Share  Yahoo Finance
  3. J&J's consumer group Kenvue launches $41B IPO  FiercePharma
  4. J&J spinoff Kenvue prices IPO at $22, toward the top end of expected range  CNBC
  5. View Full Coverage on Google News

J&J's consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut - CNBC

Google.com 

  1. J&J's consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut  CNBC
  2. J&J’s Kenvue Prices IPO at $22 Per Share  Yahoo Finance
  3. Kenvue stock opens 16% above IPO, valuing the company at $47.7 billion  MarketWatch
  4. J&J spinoff Kenvue prices IPO at $22, toward the top end of expected range  CNBC
  5. View Full Coverage on Google News





СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *